PATENT CLAIM ANALYSIS

Application Number: 15754684
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "235500"]

Abstract:
The present disclosure relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).

Claim (Index 16):
The method of  claim 15 , wherein the EZH2 inhibitor is: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15319535', '15851978', '15211792', '15359538', '15567838']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7464927784783412
- 35 USC 102 Novelty (BERT): 0.4932208392491479
- Combined Prediction Score: 0.7211655845554218
- Mean Citation Score: 231.55974
- Max Citation Score: 256.7574
- Similarity Product: 237.10124191296103

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test